1-20 of 2,432 results for subject:Brain
Librarians' tools
- Search time
- 0.272 seconds
- Solr query time
- 0.007 seconds
- Search query
- subject:Brain
- We searched for
- subject_t:Brain OR subject_ses:8775
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what assessment she has made of the level of regional disparities in access to (a) brain tumour clinical trials and (b) tissue-based precision medicine arising from variations in tumour tissue preservation facilities; and what steps her Department is taking...
To ask the Secretary of State for Health and Social Care, what assessment she has made of the level of regional disparities in access to (a) brain tumour clinical trials and (b) tissue-based precision medicine arising from variations in tumour tissue preservation facilities; and what steps her Department is taking...
I refer the Hon. Members to the answer provided on 22 September in response to Question HL2877.
To ask His Majesty's Government which bodies or officeholders are accountable for (1) collecting, (2) reporting, and (3) publishing data on (a) expenditure on brain tumours, including direct disease-specific research expenditure, (b) molecular profiling, (c) liquid biopsy testing, (d) treatment and clinical trial matching, (e) international trial participation, and (f)...
To ask His Majesty's Government which bodies or officeholders are accountable for (1) collecting, (2) reporting, and (3) publishing data on (a) expenditure on brain tumours, including direct disease-specific research expenditure, (b) molecular profiling, (c) liquid biopsy testing, (d) treatment and clinical trial matching, (e) international trial participation, and (f)...
Responsibility for the delivery of cancer services and the achievement of cancer outcomes sits with NHS England and local National Health Service organisations. The Department of Health and Social Care (DHSC) and its research partners support the evidence base, while NHS England is responsible for service delivery and improvement. Government responsibility for delivering cancer research is shared between DHSC, with research delivered by the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.
The DHSC holds data on participation in brain tumour research studies on the NIHR Research Delivery Network portfolio but does not hold data on participation in international trials. On the other data requests contained in the Noble Lord’s questions, I refer him to the answer provided in the House of Lords on 14 September in response to Question HL3172, which, for ease of reference, is reproduced below:
“I refer the Noble Lord Hunt to the answers provided on 15 July in response to Question HL1677 and 16 July in response to Question HL1674. Further to the answer provided on 15 July in response to Question HL1677, over eight years, from 2018/19 to 2025/26, UK Research and Innovation (UKRI) committed £66.3 million to brain tumour research. UKRI also supported 93 studentships over this period. All associated work packages for the National Institute for Health and Care Research Brain Tumour Research Consortium have now been fully executed. The information requested is not held by the Medicines and Healthcare products Regulatory Agency. Information on trials supported through the Cancer Vaccine Launch Pad (CVLP) can be found on their website. The platform is designed to be company and clinical trial agnostic so any company can contact the CVLP to explore how the platform can support their research. Other information is not available as it is not held in the format requested or is not held centrally.”
To ask His Majesty's Government which bodies or officeholders are accountable for figures relating to (1) expenditure on brain tumour research, (2) tumour-specific expenditure, (3) molecular testing and subsequent treatment or clinical trial matching, (4) participation in international clinical trials, and (5) patient outcomes; and where such figures are not...
To ask His Majesty's Government which bodies or officeholders are accountable for figures relating to (1) expenditure on brain tumour research, (2) tumour-specific expenditure, (3) molecular testing and subsequent treatment or clinical trial matching, (4) participation in international clinical trials, and (5) patient outcomes; and where such figures are not...
Responsibility for the delivery of cancer services and the achievement of cancer outcomes sits with NHS England and local National Health Service organisations. The Department of Health and Social Care (DHSC) and its research partners support the evidence base, while NHS England is responsible for service delivery and improvement. Government responsibility for delivering cancer research is shared between DHSC, with research delivered by the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.
The DHSC holds data on participation in brain tumour research studies on the NIHR Research Delivery Network portfolio but does not hold data on participation in international trials. On the other data requests contained in the Noble Lord’s questions, I refer him to the answer provided in the House of Lords on 14 September in response to Question HL3172, which, for ease of reference, is reproduced below:
“I refer the Noble Lord Hunt to the answers provided on 15 July in response to Question HL1677 and 16 July in response to Question HL1674. Further to the answer provided on 15 July in response to Question HL1677, over eight years, from 2018/19 to 2025/26, UK Research and Innovation (UKRI) committed £66.3 million to brain tumour research. UKRI also supported 93 studentships over this period. All associated work packages for the National Institute for Health and Care Research Brain Tumour Research Consortium have now been fully executed. The information requested is not held by the Medicines and Healthcare products Regulatory Agency. Information on trials supported through the Cancer Vaccine Launch Pad (CVLP) can be found on their website. The platform is designed to be company and clinical trial agnostic so any company can contact the CVLP to explore how the platform can support their research. Other information is not available as it is not held in the format requested or is not held centrally.”
To ask the Secretary of State for Health and Social Care, what estimate her Department has made of the funding required to address the gaps in capacity for the fresh freezing and storage of brain tumour tissue identified by NHS England, including essential supporting infrastructure; and whether she plans to...
To ask the Secretary of State for Health and Social Care, what estimate her Department has made of the funding required to address the gaps in capacity for the fresh freezing and storage of brain tumour tissue identified by NHS England, including essential supporting infrastructure; and whether she plans to...
I refer to the Hon Member to the answer given on 22 September to Question HL2877.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase funding for research into childhood brain tumours, and to improve diagnosis, treatment, care and support for children with brain tumours and their families.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase funding for research into childhood brain tumours, and to improve diagnosis, treatment, care and support for children with brain tumours and their families.
Further to the answer provided on 25 June in response to Question 9944, the National Institute for Health and Care Research has announced the co-funding of a new partnership alongside the Tessa Jowell Brain Cancer Mission and the Great Ormond Street Hospital Charity to support the development of the next generation of specialists caring for children with brain tumours. Further details can be found at the following link:
https://www.nihr.ac.uk/news/nihr-and-partners-launch-paediatric-brain-tumour-fellowship
To ask the Secretary of State for Health and Social Care, what data her department holds on the number of patients treated for traumatic head injuries following incidents involving e-scooters and e-bikes in each of the last five years.
To ask the Secretary of State for Health and Social Care, what data her department holds on the number of patients treated for traumatic head injuries following incidents involving e-scooters and e-bikes in each of the last five years.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the long-term health and care needs of people who have suffered traumatic brain injuries in e-vehicle incidents.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the long-term health and care needs of people who have suffered traumatic brain injuries in e-vehicle incidents.
To ask the Secretary of State for Health and Social Care, what assessment she has made on the adequacy of brain tumour freezer capacity across the country.
To ask the Secretary of State for Health and Social Care, what assessment she has made on the adequacy of brain tumour freezer capacity across the country.
I refer the Hon Member to the response given on 22 September to Question HL2877.
To ask the Secretary of State for Health and Social Care, for her Department's assessment of the potential merits of requiring NHS hospitals to freeze suitable brain tumour tissue for cancer treatment.
To ask the Secretary of State for Health and Social Care, for her Department's assessment of the potential merits of requiring NHS hospitals to freeze suitable brain tumour tissue for cancer treatment.
I refer the Hon Member to the response given on 22 September to Question HL2877.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 July 2026 to Question 10706 on Brain: Tumours, what progress her Department and NHS England have made with the Royal College of Pathologists on reviewing tissue retention guidance; whether that work is considering...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 July 2026 to Question 10706 on Brain: Tumours, what progress her Department and NHS England have made with the Royal College of Pathologists on reviewing tissue retention guidance; whether that work is considering...
I refer the Hon. Member to the answer provided on 16 July in response to Question 14300.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 July 2026 to Question 10706 on Brain: Tumours, what progress has been made on reviewing consent processes for the storage and future use of brain tumour tissue; whether her Department is considering a...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 July 2026 to Question 10706 on Brain: Tumours, what progress has been made on reviewing consent processes for the storage and future use of brain tumour tissue; whether her Department is considering a...
I refer the Hon. Member to the answer provided on 16 July in response to Question 14300.
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency plans to examine the impact of Depo-Provera use on trends in meningioma diagnoses.
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency plans to examine the impact of Depo-Provera use on trends in meningioma diagnoses.
I refer the Hon Member to the answer provided on 9 September in response to Question 21794.
To ask the Secretary of State for Health and Social Care, when she plans to publish her Department’s acquired brain injury action plan.
To ask the Secretary of State for Health and Social Care, when she plans to publish her Department’s acquired brain injury action plan.
Ministers are currently considering next steps and the potential for a national Acquired Brain Injury Action Plan and will set out next steps in due course.
To ask the Secretary of State for Health and Social Care, what steps are being taken to reduce the time taken for promising brain tumour treatments to progress from laboratory research to clinical trials.
To ask the Secretary of State for Health and Social Care, what steps are being taken to reduce the time taken for promising brain tumour treatments to progress from laboratory research to clinical trials.
To ask the Secretary of State for Health and Social Care, whether the rapid review of brain tumour research and the subsequent action plan will include measures on high-grade gliomas, including glioblastoma.
To ask the Secretary of State for Health and Social Care, whether the rapid review of brain tumour research and the subsequent action plan will include measures on high-grade gliomas, including glioblastoma.
To ask the Secretary of State for Health and Social Care, whether she will confirm a timeline for the appointment of the national brain cancer clinical lead.
To ask the Secretary of State for Health and Social Care, whether she will confirm a timeline for the appointment of the national brain cancer clinical lead.
To ask the Secretary of State for Health and Social Care, if she will set out the recruitment process for the planned roundtable aimed at boosting participation for brain cancer clinical trials.
To ask the Secretary of State for Health and Social Care, if she will set out the recruitment process for the planned roundtable aimed at boosting participation for brain cancer clinical trials.
To ask the Secretary of State for Education, what steps she is taking to improve educational support and outcomes for children and young people with acquired brain injury.
To ask the Secretary of State for Education, what steps she is taking to improve educational support and outcomes for children and young people with acquired brain injury.
Children with an acquired brain injury can be affected in different ways. Some brain injuries will result in a special educational need or a medical need, whilst others may affect a child in other ways. In whatever way a brain injury manifests, it is essential that the pupil’s individual needs are identified and supported appropriately. Identification and diagnosis of acquired brain injuries are the responsibility of healthcare professionals.
Through the department’s reform of the special educational needs and disabilities (SEND) programme, we have proposed the introduction of National Inclusion Standards. This will support education settings to identify and respond to needs earlier and more consistently, drawing on a broad range of evidence and professional expertise, so that all children and young people can receive the support they need to achieve and thrive.
The National Inclusion Standards will be underpinned by a £200 million training package to ensure that all teachers, educators, teaching assistants, support staff and leaders across early years, schools and post-16 settings can be trained to support pupils with SEND, and a new investment of £3.7 billion to drive more inclusive school estates and create additional specialist places.
In addition, the Department of Health and Social Care is currently developing an Acquired Brain Injury Strategy.
To ask the Secretary of State for Health and Social Care, what the timetable is for publication of the Acquired Brain Injury Action Plan.
To ask the Secretary of State for Health and Social Care, what the timetable is for publication of the Acquired Brain Injury Action Plan.
The Government recognises the profound impact that brain injuries can have on an individual and their loved ones, as well as the case for national action to improve the lives of people who have experienced an acquired brain injury (ABI).
We will set out next steps on ABI in due course.
To ask the Secretary of State for Health and Social Care, when the Medicines and Healthcare products Regulatory Agency expects to publish its research comparing the risk of meningioma associated with Depo-Provera and other contraceptives.
To ask the Secretary of State for Health and Social Care, when the Medicines and Healthcare products Regulatory Agency expects to publish its research comparing the risk of meningioma associated with Depo-Provera and other contraceptives.